|
(b)(4).The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no other incidents from this lot.Based on the information reviewed, there is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.The investigation was unable to determine a conclusive cause for the reported resistance.
|
|
It was reported that the procedure was to treat a lesion located in the non-tortuous, mildly calcified superficial femoral artery.The 5.5 x 100 supera stent was advanced and deployed in the lesion without issue; however, resistance was felt during retraction of the 5.5 x 100 mm supera stent delivery system believed to be due to a kink in the non-abbott guide wire.No adverse patient effects or clinically significant delay in the procedure were reported.No additional information was provided.
|